Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma

Second primary malignancies (SPMs) are known to be associated with neuroendocrine tumors (NETs). The association necessitates a careful assessment of the dual-tracer positron emission tomography–computed tomography (PET-CT) imaging findings to identify these malignancies earlier. Such early diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalshetty, Ashwini, Basu, Sandip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875020/
https://www.ncbi.nlm.nih.gov/pubmed/33623512
http://dx.doi.org/10.4103/wjnm.WJNM_15_20
_version_ 1783649706522443776
author Kalshetty, Ashwini
Basu, Sandip
author_facet Kalshetty, Ashwini
Basu, Sandip
author_sort Kalshetty, Ashwini
collection PubMed
description Second primary malignancies (SPMs) are known to be associated with neuroendocrine tumors (NETs). The association necessitates a careful assessment of the dual-tracer positron emission tomography–computed tomography (PET-CT) imaging findings to identify these malignancies earlier. Such early diagnosis can provide incremental benefit for screening these SPMs apart from their known applications in the management of NETs. A case of incidentally detected metachronous triple-negative breast carcinoma on dual-tracer PET-CT imaging is presented using (18)fluoro-2-deoxy-D-glucose (FDG) and (68)Ga-DOTATATE that showed a high uptake on FDG but no uptake on somatostatin receptor-based imaging.
format Online
Article
Text
id pubmed-7875020
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-78750202021-02-22 Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma Kalshetty, Ashwini Basu, Sandip World J Nucl Med Case Report Second primary malignancies (SPMs) are known to be associated with neuroendocrine tumors (NETs). The association necessitates a careful assessment of the dual-tracer positron emission tomography–computed tomography (PET-CT) imaging findings to identify these malignancies earlier. Such early diagnosis can provide incremental benefit for screening these SPMs apart from their known applications in the management of NETs. A case of incidentally detected metachronous triple-negative breast carcinoma on dual-tracer PET-CT imaging is presented using (18)fluoro-2-deoxy-D-glucose (FDG) and (68)Ga-DOTATATE that showed a high uptake on FDG but no uptake on somatostatin receptor-based imaging. Wolters Kluwer - Medknow 2020-06-27 /pmc/articles/PMC7875020/ /pubmed/33623512 http://dx.doi.org/10.4103/wjnm.WJNM_15_20 Text en Copyright: © 2020 World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Kalshetty, Ashwini
Basu, Sandip
Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma
title Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma
title_full Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma
title_fullStr Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma
title_full_unstemmed Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma
title_short Interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma
title_sort interpreting discordance on dual-tracer positron emission tomography–computed tomography in the setting of metastatic neuroendocrine tumor: detection of metachronous triple-negative breast carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875020/
https://www.ncbi.nlm.nih.gov/pubmed/33623512
http://dx.doi.org/10.4103/wjnm.WJNM_15_20
work_keys_str_mv AT kalshettyashwini interpretingdiscordanceondualtracerpositronemissiontomographycomputedtomographyinthesettingofmetastaticneuroendocrinetumordetectionofmetachronoustriplenegativebreastcarcinoma
AT basusandip interpretingdiscordanceondualtracerpositronemissiontomographycomputedtomographyinthesettingofmetastaticneuroendocrinetumordetectionofmetachronoustriplenegativebreastcarcinoma

Ejemplares similares